Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Getting Ugly

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Jun 22, 2021 10:55am

141 Views

Post# 33426968

RE:RE:RE:RE:RE:RE:RE:Getting Ugly

Not my bullboard - just when you and others spew immotive bullcrap then it deserves a response.

There are more than 65 million in equity tied up amongst investors. Take some personal responsibility for the collective and avoid throwing around whining statements if you don't get what you want overnight.

This is a junior biotech not a bluechip. Understand that and grow the f-up.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?